세계의 올리고뉴클레오티드 합성 시장(제3판) : 올리고 길이별, 용도별, 카테고리별, 유형별, 제품별, 지역별 예측 - 경영진 컨설턴트 가이드와 인공지능(AI)의 영향(2025-2029년)

OVERVIEW:

Synthetic Oligonucleotides are poised for explosive growth as gene technology moves into mainstream healthcare, food production and, even, data storage. With Synthetic DNA, organisms, like algae, are "custom designed" to produce food and medicine while consuming few resources. "Oligos" are already hard at work in both mature and emerging market segments. The possibilities, and market growth are unlimited. Our analysis shows that investors do not yet understand the scope of this technology and the enormous market opportunity. Small biotechs could become huge multinationals, all based on producing DNA and its building blocks. Learn all about it and see our forecasts in this comprehensive report.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genomics itself crosses the chasm.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants
• 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

• 2.1. What is Oligonucleotide Synthesis?
  • 2.1.1. The Enzyme Race
  • 2.1.2. Data Storage - The Elephant in the Room
• 2.2. Market Definition
  • 2.2.1. Market Size
  • 2.2.2. Currency
  • 2.2.3. Years
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Oligonucleotide Synthesis

• 3.1. Synthesis Technology
• 3.2. Automation
• 3.3. Types of Oligonucleotides
• 3.4. PCR Primers
• 3.5. PCR Assays and Panels
• 3.6. Sequencing
• 3.7. DNA Microarrays
• 3.8. Fluorescence In Situ Hybridization (FISH)
• 3.9. Antisense Oligonucleotides
• 3.10. Other Uses of Oligonucleotides
• 3.11. Relationship to CRISPR and Gene Editing

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body

5. Market Factors

• 5.1. Factors Driving Growth
  • 5.1.1. The Role of Diagnostics and the Covid Effect
  • 5.1.2. The RNA Based Vaccine
  • 5.1.3. Genomic Blizzard
  • 5.1.4. Antisense Revival
  • 5.1.5. New Applications
• 5.2. Factors Limiting Growth
  • 5.2.1. Declining Price
  • 5.2.2. Technology Lag
  • 5.2.3. COVID Realignment
• 5.3. The Next Five Years

6. Oligonucleotide Synthesis Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. Ono Pharmaceutical to acquire antisense oligonucleotide treatment
• 6.3. Codexis Enables Manufacturing of RNAi Therapeutics
• 6.4. Codexis Successfully Uses Enzymatic Synthesis
• 6.5. Oligo Factory Achieves GMP Compliance
• 6.6. Oligonucleotide Synthesis Scaled Up
• 6.7. Antisense Oligonucleotide Lowers Tau Tangles
• 6.8. Ansa Biotechnologies Synthesizes Longest Oligo at 1005 Bases
• 6.9. Agilent will double oligonucleotide capacity
• 6.10. RNA Synthesis Technology Commercialized by EnPlusOne
• 6.11. Quick and Automated Printing of Custom Oligos
• 6.12. WuXi STA Opens Large-Scale Oligo Manufacturing Facility
• 6.13. Secarna Pharmaceuticals' and Evotec Achieve Programme Designation
• 6.14. Aligos Discontinues Development of its Antisense Oligonucleotide
• 6.15. Seegene Obtains CE Mark for Oligo Based SARS-CoV-2 Assay
• 6.16. Biofidelity to Launch Mutation Detection Assay
• 6.17. Oligonucleotide Therapeutics Society Holds Meeting
• 6.18. New Oligonucleotide Synthesis Chemistry
• 6.19. Antisense Oligonucleotides Cross Rodents' Blood-Brain Barrier
• 6.20. New Rapid Multiplexed PCR Assay Uses Oligo Probes
• 6.21. MIT Devises Oligo 'File System' for DNA Data Storage
• 6.22. Nuclera Acquires E Ink Digital Microfluidics Business
• 6.23. Twist Bioscience Hits Milestone for DNA Data Storage
• 6.24. Twist Bioscience, Vivlion Partner on RNA Libraries for CRISPR
• 6.25. DNA Script Launching Benchtop Synthesizer for 'DNA on Demand'
• 6.26. RNA Disease Dx to Develop PoC Covid Test
• 6.27. Evonetix and Analog Devices Develop GEN3 DNA Synthesis Platform
• 6.28. ATDBio Receives Grant for Cancer Diagnosis Project
• 6.29. Twist Bioscience Announces Therapeutic Ab
• 6.30. Drugmakers boost oligo capacity amid Covid-19
• 6.31. Aligos Therapeutics in Study of Oligo Candidate
• 6.32. DNA Script Raises $89M for SYNTAX Launch
• 6.33. Codexis & Molecular Assemblies Partner for DNA Synthesis
• 6.34. NuProbe Licenses Oligo Technology from Rice
• 6.35. Genome editing with Cas9-oligo conjugates
• 6.36. OliX Pharma and AM Chemicals Partner for RNA Synthesis Support
• 6.37. Twist Bio To End Trade Secrets Suit
• 6.38. DNA Script, partners get grant for data storage
• 6.39. Xi's STA unit opens oligonucleotide plant

7. Profiles of Key Companies

• 7.1. Abbott Laboratories
• 7.2. Agilent
• 7.3. Ajinomoto Bio-Pharma
• 7.4. Amyris
• 7.5. Ansa BioTechnologies
• 7.6. ATG:biosynthetics
• 7.7. ATUM
• 7.8. Azenta
• 7.9. Bayer
• 7.10. Beckman Coulter Diagnostics (Danaher)
• 7.11. Becton, Dickinson and Company
• 7.12. Biogen
• 7.13. Biolytic Lab Performance
• 7.14. Biomatik
• 7.15. bioMerieux Diagnostics
• 7.16. Bioneer Corporation
• 7.17. Bio-Rad Laboratories, Inc.
• 7.18. Biospring
• 7.19. Bio-Synthesis
• 7.20. Biotage
• 7.21. Blue Heron Biotechnology (Eurofins Genomic)
• 7.22. Camena Bioscience
• 7.23. Cepheid (Danaher)
• 7.24. Chemgenes
• 7.25. Codexis
• 7.26. Cytena
• 7.27. Diasorin S.p.A.
• 7.28. DNA Script
• 7.29. Enzo Biochem
• 7.30. Eurofins Scientific
• 7.31. Eurogentec (Kaneka)
• 7.32. Evonetix
• 7.33. FASMAC
• 7.34. GE Healthcare
• 7.35. Genomatica
• 7.36. Genscript Biotech
• 7.37. Glycogene Inc.
• 7.38. Hologic
• 7.39. Hongene Biotech
• 7.40. Innovassynth
• 7.41. Integrated DNA Technologies (Danaher)
• 7.42. Ionis Pharmaceuticals
• 7.43. J&J Innovative Medicine
• 7.44. Kern Systems
• 7.45. LGC Biosearch Technologies
• 7.46. Macrogen
• 7.47. Maravai LifeSciences Holdings
• 7.48. Merck & Co., Inc
• 7.49. Microsynth
• 7.50. Millipore Sigma
• 7.51. Molecular Assemblies
• 7.52. New England Biolabs, Inc.
• 7.53. Nippon Shinyaku
• 7.54. Nitto Denko (Avecia)
• 7.55. Nuclera
• 7.56. Oligo Factory
• 7.57. Panagene
• 7.58. Primerdesign (Novacyt)
• 7.59. Qiagen
• 7.60. Revvity
• 7.61. Roche Diagnostics
• 7.62. Seegene
• 7.63. Siemens Healthineers
• 7.64. Synthego
• 7.65. TAG Copenhagen A/S
• 7.66. Thermo Fisher Scientific
• 7.67. Twist Bioscience

8. Oligonucleotide Synthesis Global Market Overview

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market Size by Length - Overview
  • 8.2.1. Table - Global Market by Length
  • 8.2.2. Chart - Global Market by Length - Base/Final Year Comparison
  • 8.2.3. Chart - Global Market by Length - Base Year
  • 8.2.4. Chart - Global Market by Length - Final Year
  • 8.2.5. Chart - Global Market by Length - Share by Year
  • 8.2.6. Chart - Global Market by Length - Segment Growth
• 8.3. Global Market Size by Application - Overview
  • 8.3.1. Table - Global Market by Application
  • 8.3.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 8.3.3. Chart - Global Market by Application - Base Year
  • 8.3.4. Chart - Global Market by Application - Final Year
  • 8.3.5. Chart - Global Market by Application - Share by Year
  • 8.3.6. Chart - Global Market by Application - Segment Growth
• 8.4. Global Market Size by Product - Overview
  • 8.4.1. Table - Global Market by Product
  • 8.4.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 8.4.3. Chart - Global Market by Product - Base Year
  • 8.4.4. Chart - Global Market by Product - Final Year
  • 8.4.5. Chart - Global Market by Product - Share by Year
  • 8.4.6. Chart - Global Market by Product - Segment Growth
• 8.5. Global Market Size by Category - Overview
  • 8.5.1. Table - Global Market by Category
  • 8.5.2. Chart - Global Market by Category - Base/Final Year Comparison
  • 8.5.3. Chart - Global Market by Category - Base Year
  • 8.5.4. Chart - Global Market by Category - Final Year
  • 8.5.5. Chart - Global Market by Category - Share by Year
  • 8.5.6. Chart - Global Market by Category - Segment Growth
• 8.6. Global Market Size by Type - Overview
  • 8.6.1. Table - Global Market by Type
  • 8.6.2. Chart - Global Market by Type - Base/Final Year Comparison
  • 8.6.3. Chart - Global Market by Type - Base Year
  • 8.6.4. Chart - Global Market by Type - Final Year
  • 8.6.5. Chart - Global Market by Type - Share by Year
  • 8.6.6. Chart - Global Market by Type - Segment Growth

9. Global Market by Length

• 9.1. less than 20 mer Market
  • 9.1.1. Table - less than 20 mer Market by Country
  • 9.1.2. Chart - less than 20 mer Market Segment Growth
• 9.2 21-50 mer Market
  • 9.2.1. Table - 21-50 mer Market by Country
  • 9.2.2. Chart - 21-50 mer Market Segment Growth
• 9.3. 51-100 mer Market
  • 9.3.1. Table - 51-100 mer Market by Country
  • 9.3.2. Chart - 51-100 mer Market Segment Growth
• 9.4. greater than 100 mer Market
  • 9.4.1. Table - greater than 100 mer Market by Country
  • 9.4.2. Chart - greater than 100 mer Market Segment Growth

10. Global Market by Application

• 10.1. Research Market
  • 10.1.1. Table - Research Market by Country
  • 10.1.2. Chart - Research Market Segment Growth
• 10.2. Diagnostics Market
  • 10.2.1. Table - Diagnostics Market by Country
  • 10.2.2. Chart - Diagnostics Market Segment Growth
• 10.3. Therapeutics Market
  • 10.3.1. Table - Therapeutics Market by Country
  • 10.3.2. Chart - Therapeutics Market Segment Growth
• 10.4. Data Market
  • 10.4.1. Table - Data Market by Country
  • 10.4.2. Chart - Data Market Segment Growth

11. Global Market by Product

• 11.1. Oligonucleotides Market
  • 11.1.1. Table - Oligonucleotides Market by Country
  • 11.1.2. Chart - Oligonucleotides Market Segment Growth
• 11.2. Instruments Market
  • 11.2.1. Table - Instruments Market by Country
  • 11.2.2. Chart - Instruments Market Segment Growth
• 11.3. Nucleosides Market
  • 11.3.1. Table - Nucleosides Market by Country
  • 11.3.2. Chart - Nucleosides Market Segment Growth
• 11.4. Other Reagents Market
  • 11.4.1. Table - Other Reagents Market by Country
  • 11.4.2. Chart - Other Reagents Market Segment Growth

12. Global Market by Category

• 12.1. Primer Market
  • 12.1.1. Table - Primer Market by Country
  • 12.1.2. Chart - Primer Market Segment Growth
• 12.2. Probe Market
  • 12.2.1. Table - Probe Market by Country
  • 12.2.2. Chart - Probe Market Segment Growth
• 12.3. DNA Market
  • 12.3.1. Table - DNA Market by Country
  • 12.3.2. Chart - DNA Market Segment Growth
• 12.4. RNA Market
  • 12.4.1. Table - RNA Market by Country
  • 12.4.2. Chart - RNA Market Segment Growth
• 12.5. Other Nucleic Acid Market
  • 12.5.1. Table - Other Nucleic Acid Market by Country
  • 12.5.2. Chart - Other Nucleic Acid Market Segment Growth

13. Global Market by Type

• 13.1. Standard Oligonucleotides Market
  • 13.1.1. Table - Standard Oligonucleotides Market by Country
  • 13.1.2. Chart - Standard Oligonucleotides Market Segment Growth
• 13.2. Custom Oligonucleotides Market
  • 13.2.1. Table - Custom Oligonucleotides Market by Country
  • 13.2.2. Chart - Custom Oligonucleotides Market Segment Growth

14. Appendices

• 14.1. Typical Oligo Synthesis Price Lists
• 14.2. Medicare Clinical Lab Fee Schedule
• 14.3. Drug Approvals by Molecule Type - A Seven Year View
• 14.4. Growth of Approved IVD Test Menu
• 14.5. Growth of Approved Average IVD Test Fee
• 14.6. Share of Pharma R&D by Country